Research Ready offers community driven training and educational support for research coordinators, research personnel and new investigators in Ontario. Research Ready leverages existing programs and material, including programs developed by Ontario centers, with the aim of supporting the Ontario research ecosystem. Members of the research community can contact CTO to suggest topics or speakers for our monthly webinar series, access past recordings of webinars, share stories and best practices and sign up for our community newsletter to receive regular updates.
Rosemarie is a Registered Nurse with a Bachelor of Science degree in Nursing and a Masters in Health Management. She has certifications as a Clinical Research Professional with the Society of Clinical Research Associates (SoCRA) and a Certified Health Executive with the Canadian College Health Leaders. Rosie, currently holds the position of Clinical Research Manager and Project Manager at the University Health Network, a tertiary and academic based hospital in Toronto. Rosie specializes in Clinical Research Operations and has coordinated and managed studies in many therapeutic areas and in all phases of clinical trials. This specialty positioned her to project manage several COVID studies throughout the pandemic. Rosie is instrumental in the startup and implementation of a decentralized study called STOPCoV and currently oversees a research team of Investigators, coordinators and analysts.
Velma Marzinotto is an independent clinical research consultant. She has over 18 years of experience as a clinical research quality auditor. Velma developed the internal research quality audit program at Unity Health Toronto – St. Michael’s Hospital and The Hospital for Sick Children (SickKids). In addition, she also facilitated clinical research by providing education to researchers. Previously, Velma worked as a clinical research nurse coordinator managing clinical trials in the use of anticoagulants in children, a hematology/oncology nurse educator and a hematology/oncology staff nurse at SickKids and a general duty RN in pediatrics at McMaster University Medical Centre. Velma obtained her BScN from McMaster University, Hamilton.
Margaret Molnar is clinical trials expert with broad drug development knowledge. She has over 15 years of experience working in the clinical research field. Margaret is currently a Senior Clinical Operations Lead at Hoffmann La Roche with a focus on study management at a Canadian and global level across multiple therapeutic areas. Through her career she has held a variety of study and people management positions across the CRO, hospital, and sponsor settings.
Emily is an experienced clinical research professional with experience at several tertiary and quaternary care academic hospitals in Toronto both in adult and pediatric settings. She completed her BSc in Integrated Science at McMaster University, followed by postgraduate education in Clinical Research at Humber College, and holds the Certified Clinical Research Professional designation from SOCRA. Currently, Emily is a Clinical Research Manager at University Health Network where she oversees a team of clinical research coordinators in the Cancer Clinical Research Unit (CCRU), spanning various solid tumour, malignant hematology, and benign hematology disease sites in both interventional clinical trials and non-interventional research studies. Previously Emily worked at SickKids in the Hematology/Oncology Clinical Trials Support Unit focusing on neuro-oncology and international investigator-initiated trials, and got her start in clinical research at Mount Sinai Hospital with both the Retroperitoneal Sarcoma and the Peritoneal Malignancy Surgical Oncology teams.
In this session, we’ll cover the foundation of how to establish a metrics program — focusing on the Who, What, Where, When, Why, and How. Metrics are the cornerstone for measuring success, and anyone can become a metrics master (promise!). We’ll share our experience establishing a metrics program, discuss lessons learned, go over best practices, and share case scenarios that highlight the value we have gained from leaning in to the numbers.
Yvan Lamoureux, CEO and Founder of ResearchMetrix discusses how going beyond protocol targets and gaining a better understanding of patient engagement produces more positive patient outcomes. Learn why digital online recruitment tactics have become fragmented and require a balanced, integrated, multi-channel approach. Yvan will describe how pre-screening for trials differs from practicing medicine and how to become more effective in recruitment efforts.
In part two of our series on clinical trial finance, Entela Zaffino and Jackie Anucha from The Hospital for Sick Children look at clinical trial unit finance oversight including:
In part one of our series on clinical trial finance, Shaherose Nanji & Shauna Kirk from The Hospital for Sick Children focused on clinical trial finance operations including:
Real data is often messy and incomplete, and its important to understand how to handle missing data. Database administrator and analyst, Chris Battiston, discusses causes and types of missing data, how to reduce missing data during the design phase, data quality checks and how to handle missing data during those checks/analyses.
Panelists Emily Taylor (UHN), Greg Staios (Seneca College), and Margaret Molnar (Hoffman-La Roche Limited) discuss different paths and careers in research, share their own experiences and tips, and address audience questions.
As a result of the pandemic there has been a desire to shift many paper-based processes to an electronic format. Join us on September 13th with Megan Reilly, Clinical Research & Compliance Officer at the University of Ottawa Heart Institute (UOHI), to discuss the implementation of regulatory eBinders. Megan will be speaking on challenges, solutions, implementation, pros, and cons of regulatory eBinders.
Lauren Gogo, Manager of Research Contracts at Hamilton Health Sciences Corporation, discusses clinical trial agreement basics, best practices, tools, and different ways to approach a contract.
Jill Beckley from the Division of Haematology/Oncology Clinical Trials Support Unit at the Hospital for Sick Children shares how cancer trials have evolved due to the COVID-19 pandemic. Jill discusses best practices for current processes, how to improve quality and increase efficiency, and eliminating silos between research and clinical groups.
Research Ready Advisory Group Member Rosemarie Clarke shares best practices, tips, and practical solutions for decentralized clinical trials. Rosemarie discusses REB applications, recruitment strategies, and digital integration.
Lanre Tunji-Ajayi of the Sickle Cell Awareness Group of Ontario (SCAGO) discus diversity in research. Major themes include the importance of diversity in clinical trials, steps towards building trust and awareness of clinical trials in specific communities, and practical tips on working with diverse communities participating in research.
Speakers from Southlake and the Population Health Research Institute share their experience and learnings using remote consent within a DCT study model, focusing on rapport with participants, privacy, and processes used.
Panelists from Princess Margaret Cancer Centre, CHEO Research Institute, and Lawson Health Research Institute discuss tips and tricks for Health Canada inspection readiness.
Ellen Morrison and Stephanie Badour share some best practices for the preparation and execution of a remote monitoring visit. Whether your site has full access EMR, uses redacted documents or video conference platforms, there are ways to improve the efficiency of this monitoring approach that can be easily adopted. Ellen and Stephanie have been working together in the peer-to-peer monitoring program and more recently using remote monitoring, and are going to share their best tips and tricks with you in this session.
Sarah Best, Clinical Trials Research Manager for the Cognitive Clinical Research Group (CCRG) at Parkwood Institute, discusses how to assess a clinical trial budget. She helps identify important cost elements to consider for clinical trial budgeting and provides techniques and tools to assess a complete trial budget with confidence.
Dawn Richards, founder of Five02 Labs Inc. and Director of Patient and Public Engagement at CTO, discusses how working with people who live with conditions brings different perspectives to the work. Dawn provides practical guidance on how to start the process and where to find helpful resources.
Geetha Sanmugalingham, Certified Clinical Research Professional, discusses REDCap: a secure web application for building and managing online surveys and databases. Geetha shares how REDCap can be used to design a data capture form specific to your research study and how to effectively take the collected data and present it in a report using it for analysis, quality improvement, audits, and more.
Sign-up to receive our monthly newsletter with upcoming events, best practices, updates and more.
As part of CTO’s efforts to engage patients and the public with clinical trials, we are leading and actively participating in initiatives to build resources and tools to help the community work together.
CTOs QuickSTART program is aimed at improving study start-up efficiency. This budget building tool is meant to be customized to a research department and then further customized per research protocol as needed.
The ICH efficacy guidelines concerned with the design, conduct, safety and reporting of clinical trials.
Compliance with Part C, Division 5 regulations is required when conducting clinical trials of drugs in human subjects in Canada.
The Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS or the Policy) is a joint policy of Canada’s three federal research agencies. The Agencies have therefore adopted this Policy as a benchmark for the ethical conduct of research involving humans.
This International Standard addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical.
Provides guidance to all sponsors (e.g., industry, academic, contract research organization) seeking authorization to sell or import a drug for the purpose of a clinical trial in Canada.
This guidance document provides assistance to manufacturers and importers in preparing the documentation necessary to obtain an authorization for the sale and importation of a medical device under an investigational testing application (ITA) to perform a clinical trial in Canada with a pre-approved medical device Class II, III and IV (Non-IVDD).
Code of Federal Regulations for Investigational New Drugs (INDs), New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs) and Biologics License Applications (BLAs). 21CFR Part 50 and 21CFR Part 312 regulate clinical investigations of medical products in the US.
The OHRP provides leadership in the protection of the rights, welfare, and wellbeing of human subjects involved in research conducted or supported by the U.S. Department of Health and Human Services (HHS).
